After First Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from After First Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In After First Dose Today - Breaking & Trending Today

Patients with chronic liver disease & intractable pruritus

Published: May 2, 2022

Nalfurafine capsules 2.5 μg, oral dispersing tablets 2.5 μg) in 1,186 patients with chronic liver disease and intractable pruritus.

Source: dovepress.com

Related Topics:

Nalfurafine RemitchToray Industries IncJapanese Ministry Of HealthAdministration ChildJapanese Pharmaceutical Affairs LawResearch Laboratories Of Toray Industries IncDrug UsePharmaceutical Research LaboratoriesToray IndustriesVisual Analog ScaleSpecific Drug Use SurveyJapanese MinistryGood Post Marketing Study PracticeConducting Post Marketing SurveillanceJapanese Pharmaceutical AffairsDrug DependenceAdverse Drug ReactionsJapanese LawMedical Devices LawAdverse DrugPatient CharacteristicsGeneral AssessmentDitch ImprovementBaseline PatientHepatic Cancer